We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+13.69%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$2.85B
AUM Growth
+$268M
Cap. Flow
-$44.9M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.28%
Holding
448
New
36
Increased
128
Reduced
236
Closed
29

Top Sells

Rank Stock Value
1
PSN icon
Parsons
PSN
+$16.9M
2
FN icon
Fabrinet
FN
+$16M
3
PXD
Pioneer Natural Resource Co.
PXD
+$10.6M
4
MAS icon
Masco
MAS
+$9.31M
5
AAPL icon
Apple
AAPL
+$8.74M

Sector Composition

Rank Sector Weight
1 Technology 21.98%
2 Financials 15.97%
3 Healthcare 11.39%
4 Industrials 11.23%
5 Consumer Discretionary 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWI icon
351
Power Integrations
POWI
$3.46B
$995K 0.03%
12,118
-1,638
-12% -$126K
TDW icon
352
Tidewater
TDW
$4.46B
$983K 0.03%
+13,635
New +$883K
RDNT icon
353
RadNet
RDNT
$6.08B
$976K 0.03%
28,055
-13,997
-33% -$442K
RITM icon
354
Rithm Capital
RITM
$5.65B
$970K 0.03%
90,830
-90,670
-50% -$902K
BANC icon
355
Banc of California
BANC
$3B
$966K 0.03%
71,909
+21,474
+43% +$265K
COHR icon
356
Coherent
COHR
$63.6B
$964K 0.03%
+22,138
New +$798K
GPOR icon
357
Gulfport Energy Corp
GPOR
$2.97B
$961K 0.03%
7,217
-977
-12% -$126K
XENE icon
358
Xenon Pharmaceuticals
XENE
$6.21B
$945K 0.03%
20,520
-2,781
-12% -$98.3K
NEO icon
359
NeoGenomics
NEO
$2.14B
$941K 0.03%
58,158
-7,852
-12% -$128K
GMS
360
DELISTED
GMS Inc
GMS
$931K 0.03%
11,301
-1,529
-12% -$102K
VRT icon
361
Vertiv
VRT
$104B
$926K 0.03%
+19,280
New +$821K
CAH icon
362
Cardinal Health
CAH
$55.5B
$916K 0.03%
9,089
-6,761
-43% -$671K
STRL icon
363
Sterling Infrastructure
STRL
$16.2B
$887K 0.03%
+10,097
New +$730K
UFPT icon
364
UFP Technologies
UFPT
$2.51B
$883K 0.03%
5,135
+1,567
+44% +$254K
NMIH icon
365
NMI Holdings
NMIH
$3.32B
$881K 0.03%
+29,687
New +$829K
HCI icon
366
HCI Group
HCI
$2.36B
$864K 0.03%
9,882
+2,021
+26% +$148K
IMVT icon
367
Immunovant
IMVT
$8.24B
$858K 0.03%
20,370
-2,756
-12% -$101K
ITCI
368
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$833K 0.03%
+11,631
New +$669K
XYZ
369
Block Inc
XYZ
$47.5B
$827K 0.03%
+10,696
New +$605K
PCVX icon
370
Vaxcyte
PCVX
$8.67B
$814K 0.03%
12,951
+4,558
+54% +$237K
MBB icon
371
iShares MBS ETF
MBB
$38.9B
$804K 0.03%
8,550
CHDN icon
372
Churchill Downs
CHDN
$6.02B
$791K 0.03%
5,861
-6,013
-51% -$714K
DOC icon
373
Healthpeak Properties
DOC
$14.4B
$776K 0.03%
39,170
-214,686
-85% -$3.78M
DXCM icon
374
DexCom
DXCM
$33.1B
$768K 0.03%
6,190
-5,900
-49% -$603K
HOLX
375
DELISTED
Hologic
HOLX
$767K 0.03%
10,728
-751
-7% -$52.3K

Similar funds

Chartwell Investment Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Chartwell Investment Partners held 448 positions worth $2.85B, up 10% from $2.58B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Chartwell Investment Partners's Q4 2023 filing shows 36 new, 128 increased, 236 reduced and 29 closed positions. Its largest new stake was Applied Materials: 47,430 shares worth $7.69M. The largest sale was Parsons, an estimated $16.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

  • Chartwell Investment Partners's largest Q4 2023 buy was Applied Materials: 47,430 shares worth $7.69M.
  • Chartwell Investment Partners added most to Diamondback Energy in Q4 2023, an estimated $9.67M increase.
  • Chartwell Investment Partners's biggest Q4 2023 reduction was Fabrinet, cutting an estimated $16M.
  • Chartwell Investment Partners fully exited Parsons in Q4 2023, selling an estimated $16.9M.
  • Chartwell Investment Partners's ten largest holdings make up 16% of its $2.85B portfolio in Q4 2023.
  • Chartwell Investment Partners opened 36 new positions and closed 29 in Q4 2023.
  • Chartwell Investment Partners's portfolio value rose 10% quarter-over-quarter to $2.85B.

Based on Chartwell Investment Partners's 13F filing for Q4 2023, filed 15 Feb 2024.